Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04623515 · ClinicalTrials.gov registry record
Radiation Therapy on Pelvic Floor Disorders in Women
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- 49
- Enrollment target
NCT04623515: Clinical Trial study, sponsored by Wake Forest University Health Sciences.
NCT04623515 is a clinical trial that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 49 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04623515 was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- 49 participants
- Enrollment target
Study Summary
Investigators propose a retrospective cohort study to examine the impact of radiation therapy on the global pelvic floor function of women who have completed the immediate surveillance period for colorectal cancer
Primary Outcome
The ICIQ-FLUTS is a 12-item validated, self-administered questionnaire that is derived from the Bristol Female Lower Urinary Tract Symptoms (BF-LUTS) questionnaire and designed for use in women and to assess urinary symptoms and effects on quality of life. There are 3 subscales within this instrument to assess incontinence, voiding and filling. Investigators will specifically use the incontinence subscale as the primary outcome. The instrument is based on 5 questions, with possible answers on a
Interventions
- OTHER REDCap Questionnaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2021-05-05 |
| Est. Completion | 2022-04-14 |
Why NCT04623515 stopped before completion
NCT04623515 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 49 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which REDCap Questionnaires is the first listed.
NCT04623515 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04623515 about?
NCT04623515 is a clinical study titled "Radiation Therapy on Pelvic Floor Disorders in Women". Investigators propose a retrospective cohort study to examine the impact of radiation therapy on the global pelvic floor function of women who have completed the immediate surveillance period for colorectal cancer
What is the current status of trial NCT04623515?
This trial is currently terminated. The enrollment target is 49 participants. The study started on 2021-05-05. Estimated completion is 2022-04-14.
What interventions are being tested in trial NCT04623515?
The interventions under investigation include: REDCap Questionnaires (OTHER).
Who is sponsoring clinical trial NCT04623515?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI